search
Back to results

Effects of Exercise on Cognitive Function in Glioma Patients

Primary Purpose

Low Grade Glioma of Brain, Anaplastic Glioma of Brain

Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
physical exercise
Sponsored by
Tilburg University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Low Grade Glioma of Brain

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Grade II and III gliomas
  • age < 50 years
  • Karnofsky score > or equal 80
  • clinically stable for a minimum of 6 months prior to study entry
  • no recent anti-tumor treatment
  • interested in undergoing a physical exercise program
  • mild to moderate neuropsychological impairment based on normative comparison of objective test performance
  • relative VO2peak that leaves room for further improvement of cardiorespiratory fitness.

Exclusion Criteria:

  • patients with serious orthopedic conditions or motor deficits
  • patients with serious cardiovascular, cardiopulmonary and neurological conditions (or risks)
  • patients judged to have psychiatric (including alcohol and drug abuse)
  • patients with severe cognitive problems
  • patients who report to engage in vigorous exercise (≥7 METs) for more than 20 minutes on at least 3 days per week on a regular basis will be excluded

For assessment purposes, study participants will need to have basic fluency in the Dutch language.

Sites / Locations

  • Tilburg University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

physical exercise

Active control group

Arm Description

Patients will exercise three times per week for 6 months home-based exercise intervention. Session duration will vary between 20 minutes and 45 minutes.

Patients in the active control group will be advised to walk regularly based on brochures from 30minutenbewegen.nl

Outcomes

Primary Outcome Measures

cognitive function as measured by neuropsychological tests
neuropsychological test battery will be administered to patients at baseline and immediately after the intervention at 6 months

Secondary Outcome Measures

Objective measures of physical fitness measured by cardiopulmonary exercise test (CPET)
Intervention-related improvement of physical fitness will be assessed with a maximum cardiopulmonary exercise test (CPET). VO2 and of course adverse events are recorded immediately after the intervention ended at 6 months

Full Information

First Posted
July 15, 2013
Last Updated
August 3, 2015
Sponsor
Tilburg University
search

1. Study Identification

Unique Protocol Identification Number
NCT02303938
Brief Title
Effects of Exercise on Cognitive Function in Glioma Patients
Official Title
A Pilot Randomized Controlled Trial on the Feasibility and Efficacy of an Exercise Intervention to Improve Cognitive Functioning in Patients With Glioma
Study Type
Interventional

2. Study Status

Record Verification Date
August 2015
Overall Recruitment Status
Completed
Study Start Date
August 2013 (undefined)
Primary Completion Date
July 2015 (Actual)
Study Completion Date
July 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Tilburg University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The objective of this pilot randomized controlled trial (RCT) is to assess the feasibility and to determine the effect size of an exercise program in improving objective cognitive functioning.
Detailed Description
Clinical stable patients with 1) low grade glioma (LGG) or 2) anaplastic glioma under age 70 will undergo a home-based exercise program (intervention) or will be assigned to the active controle group. Patients in the intervention group will undergo a 6-month home-based exercise intervention. An individual exercise prescription will be based on the patients' level of aerobic fitness (VO2peak) as measured with cardiopulmonary testing (CPET; on a cycle ergometer with ECG and gas exchange measurement) at baseline. Patients will exercise (e.g., running, biking, swimming) three times per week for 6 months. Session duration will vary between 20 minutes and 45 minutes. Patients in the active control group will be advised to walk regularly based on brochures from 30minutenbewegen.nl. All primary and secondary outcomes will be assessed at baseline (T0; prior to randomization), and at completion of the 6-month exercise intervention (T1), and at a similar time-point for patients in the active control group. These will include indicators of feasibility (accrual, adherence, compliance and attrition), subjective and objective physical fitness measures, neuropsychological performance scores, and self-reported cognitive symptoms and mental wellbeing.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Grade Glioma of Brain, Anaplastic Glioma of Brain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
physical exercise
Arm Type
Experimental
Arm Description
Patients will exercise three times per week for 6 months home-based exercise intervention. Session duration will vary between 20 minutes and 45 minutes.
Arm Title
Active control group
Arm Type
No Intervention
Arm Description
Patients in the active control group will be advised to walk regularly based on brochures from 30minutenbewegen.nl
Intervention Type
Behavioral
Intervention Name(s)
physical exercise
Intervention Description
Patients in the intervention group will undergo a 6-month home-based exercise intervention. Patients will exercise (e.g., running, biking, swimming) three times per week for 6 months. Session duration will vary between 20 minutes and 45 minutes.
Primary Outcome Measure Information:
Title
cognitive function as measured by neuropsychological tests
Description
neuropsychological test battery will be administered to patients at baseline and immediately after the intervention at 6 months
Time Frame
6 months after the initial assessment
Secondary Outcome Measure Information:
Title
Objective measures of physical fitness measured by cardiopulmonary exercise test (CPET)
Description
Intervention-related improvement of physical fitness will be assessed with a maximum cardiopulmonary exercise test (CPET). VO2 and of course adverse events are recorded immediately after the intervention ended at 6 months
Time Frame
6 months after the initial assessment
Other Pre-specified Outcome Measures:
Title
Patient reported outcome measured with self-reported questionnaires
Description
mood, sleep, fatique, quality of life, and depression are measured with self-reported questionaires at baseline and after intervention at 6 months such as Profile of Mood States (POMS) brief, Multidimensional Fatigue Inventory (MFI), Pittsburgh Sleep Inventory, MOS SF-36 Item Health Survey SF-36, and Brain-cancer specific HRQL questionnaire (QLQ-BN20)
Time Frame
6 months after the initial assessment
Title
Subjective cognition measured with Cognitive Functioning Scale (CFS) and Cognitive Failures Questionnaire (CFQ)
Description
Subjective cognition is measured with self-reported questionaire at baseline and after intervention at 6 months
Time Frame
6 months after the initial assessment
Title
Mental well-being measured with self-reported questionnaires
Description
Mental well-being is measured with specific questionaire at baseline and after intervention at 6 months
Time Frame
6 months after the initial assessment

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Grade II and III gliomas age < 50 years Karnofsky score > or equal 80 clinically stable for a minimum of 6 months prior to study entry no recent anti-tumor treatment interested in undergoing a physical exercise program mild to moderate neuropsychological impairment based on normative comparison of objective test performance relative VO2peak that leaves room for further improvement of cardiorespiratory fitness. Exclusion Criteria: patients with serious orthopedic conditions or motor deficits patients with serious cardiovascular, cardiopulmonary and neurological conditions (or risks) patients judged to have psychiatric (including alcohol and drug abuse) patients with severe cognitive problems patients who report to engage in vigorous exercise (≥7 METs) for more than 20 minutes on at least 3 days per week on a regular basis will be excluded For assessment purposes, study participants will need to have basic fluency in the Dutch language.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karin Gehring, PhD
Organizational Affiliation
Tilburg University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Tilburg University
City
Tilburg
State/Province
Nood-Brabant
ZIP/Postal Code
5037 AB
Country
Netherlands

12. IPD Sharing Statement

Learn more about this trial

Effects of Exercise on Cognitive Function in Glioma Patients

We'll reach out to this number within 24 hrs